Latest Breaking News On - Ken song - Page 2 : comparemela.com

Bristol Myers Squibb to acquire RayzeBio for $4.1 billion in cash

American multinational pharmaceutical company Bristol Myers Squibb on Tuesday said it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business

Bristol Myers Squibb Invests $4.1B for Acquisition of RayzeBio to Shore Up Cancer Therapy Portfolio

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

Bristol-Myers Squibb Acquires RayzeBio

The acquisition will bolster the pharma giant's cancer drug portfolio.

Bristol Myers Squibb says billion-dollar acquisitions will enhance neuroscience, cancer care

Bristol Myers Squibb Invests $4.1B for Acquisition of RayzeBio to Shore Up Cancer Therapy Portfolio

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.